Cytokines may influence tumor growth and spread: An in vitro study in two human cancer cell lines

International Journal of Clinical and Laboratory Research

Volumn 26, Issue 4, 1996, Pages 240-244

  Panozzo, M P ^a   Basso, D ^a   De Paoli, M ^a   Carraro, P ^a   Burighel, D ^a   Plebani, M ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Centre for Biomedical Research   (Italy)

Author keywords

Cell proliferation; Colon cancer; Cytokines; Metastasis; Pancreatic cancer

Indexed keywords

EID: 0030453117     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02602956     Document Type: Article

References (37)

1. Hart IR, Saini A. Biology of tumour metastasis. Lancet 1992; 339: 1453.
2. Aznavoorian S, Murphy AN, Stetler-Stevenson G, Liotta LA. Molecular aspects of tumor cell invasion and metastasis. Cancer 1993; 71: 1368.
3. Van Roy F, Mareel M. Tumor invasion: effects of cell adhesion and motility. Trends Cell Biol 1992; 2: 163.
4. Jiang WG, Puntis MCA, Hallett MB. Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Br J Surg 1994; 81: 1576.
5. Zetter BR. The cellular basis of site-specific tumor metastasis. N Engl J Med 1990; 322: 605.
6. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991; 51: 5054s.
7. Dano K, Andreason PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985, 44: 139.
8. Liu G, Shuman A, Cohen RL. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer 1995; 60: 501.
9. Damjanovich L, Turzò C, Adany R. Factors involved in the plasminogen activation system in human breast tumours. Thromb Haemost 1994; 71: 684.
10. Bianchi E, Cohen RL, Dai A, Thor AT, Shuman MA, Smith HS. Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer. Int J Cancer 1995p; 60: 597.
11. Noguchi-Takino M, Endo Y, Yonemura Y, Sasaki T. Relationship between expression of plasminogen activator system and metastatic ability in human cancers. Int J Oncol 1996; 8: 97.
12. Bleady R, Tzanakis GN, Schwalke MA, Wanebo H, Vezeridis MP. Epidermal growth factor stimulation and metastatic rate in human pancreatic carcinoma cell lines. J Surg Res 1990; 49: 276.
13. Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR. Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. J Pathol 1991; 163: 111.
14. Baldwin RL, Korc M. Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. Growth Factors 1993; 8: 23.
15. Rodeck U, Bossler A, Graeven U, Fox FE, Novell PC, Knabbe C, Kari C. Transforming growth factor B production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res 1994; 54: 575.
16. Holting T, Zileke A, Siperstein AE, Clark OH, Duh Q. Transforming growth factor-B1 is a negative regulator for differential thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines. J Clin Endocrinol Metab 1994; 79: 806.
17. Walker RA, Dearing SJ, Gallachei B. Relationship of transforming growth factor B1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer 1994; 69: 1160.
18. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw 1994; 5: 517.
19. Boraschi D, Villa L, Volpini G, Bossù P, Censini S, Ghiara P, Scapigliat G, Nencioni L, Baratalini M, Matteucci G, Cioli F, Carnasciali M, Olmastroni E, Mengozzi M, Ghezzi P, Tagliabue A. Differential activity of interleukin 1 A and interleukin 1 B in the stimulation of the immune response in vivo. Eur J Immunol 1990; 20: 317.
20. Ebina T, Ishikawa L. Antitumor effect of interleukin-1 beta in the double grafted tumor system. Jpn J Cancer Res 1989; 80: 570.
21. Dejana E, Bertocchi F, Bortolami MC, Regonesi C, Tonta A, Breviario F, Giavazzi R. Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. J Clin Invest 1988; 82: 1466.
22. Giavazzi R, Garofalo A, Bani MR, Abbate M, Ghezzi P, Boraschi D, Mantovani A, Dejana E. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 1990; 50: 4771.
23. Burrows FJ, Haskard DO, Hart IR, Marshall JF, Selkirk S, Poole S, Thorpe PE. Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro. Cancer Res 1991; 51: 4768.
24. Chirivi RGS, Garofalo A, Martin Padura I, Mantovani A, Giavazzi R. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system. Cancer Res 1993; 53: 5051.
25. Vidal-Vanaclocha F, Amezaga C, Asumendi A, Kaplanski G, Dinarello CA. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 1994; 54: 2667.
26. Yunis AA, Arimura GK, Russin DJ. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int J Cancer 1977; 19: 128.
27. Zupi G, Marangolo M, Arancia G, Greco C, Laudonio N, Iosi F, Formisano G, Malorni W. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line. Cancer Res 1988; 48: 6193.
28. Cohen MC, Cohen S. Cytokine function. A study in biological diversity. Am J Clin Pathol 1996; 105: 589.
29. Opdenakker G, Van Damme J. Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine 1992; 4: 251.
30. Enayati P, Brennan MF, Fong Y. Systemic and liver cytokine activation. Arch Surg 1994; 129: 1159.
31. Joh T, Itoh M, Yashue N, Niyamoto T, Iwai A, Matsusako K, Endoh K, Takeuchi T, Moriyama A, Kato T, Tanaka R. A sensitive immunoassay system of rat epidermal growth factor in biological fluids and tissue extracts. Acta Endocrinol (Copenh) 1989; 120: 616.
32. Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Imai Y, Shimomukai H, Nomura Y, Matsuda Y, Matsuzawa Y. High levels of transforming growth factor B1 in patients with colorectal cancer: association with disease progression. Gastroenterology 1996; 110: 375.
33. Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Glod LI, Korc M. Enhancement expression of transforming growth factor B isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993; 105: 1846.
34. Ito N, Kawata S, Tamura S, Shirai Y, Kiso S, Tsushima H, Matsuzawa Y. Positive correlation of plasma transforming growth factor-betal levels with tumor vascularity in hepatocellular carcinoma. Cancer Lett 1995; 89: 45.
35. Fischer JR, Darjes H, Lahm H, Schindel M, Drings P, Krammer PH. Constitutive secretion of bioactive transforming growth factor beta 1 by small cell lung cancer cell lines. Eur J Cancer 1994; 30A: 2125.
36. Basso D, Plebani M, Fogar P, Panozzo MP, Meggiato T, De Paoli M, Del Favero G. Insulin-like growth factor-I, interleukin-1 A and B in pancreatic cancer: role in tumor invasiveness and associated diabetes. Int J Clin Lab Res 1995; 25: 40.
37. Fratelli M, Gagliardini V, Galli G, Gnocchi P, Ghiara P, Ghezzi P. Autocrine interleukin-1 beta regulates both proliferation and apoptosis in EL4-6.1 thymoma cells. Blood 1995; 85: 3532.